First published · Last updated
Disrupting aberrant EGFR catalytic trimers reverses T790M gefitinib resistance
A preprint posted to openRxiv on 2026-09-25 reports that disrupting EGFR catalytic trimers can reverse T790M-associated gefitinib resistance. The source provided is a posted content entry with no additional methodological or outcome details in the supplied record.
Categories: science-and-space, public-health
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 5/10
- Geographic reach
- 1/10
- Global importance
- 3/10
- Impact magnitude
- 3/10
- Positivity
- 6/10
- Urgency
- 2/10
Why it matters
The report describes a potential approach to overcome a form of drug resistance in EGFR-mutant cancers.

